Inandex

Dexamethasone phosphate, the active ingredient in Inandex, is a corticosteroid (glucocorticoid) presented as a sterile injectable solution for intraarticular, intramuscular and intravenous use. It is employed to reduce inflammation and modulate immune responses in a range of acute and chronic conditions.

GNH USA supplies Inandex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Inandex, a glucocorticoid, is indicated for several inflammatory and immune‑mediated disease groups.

- Inflammatory conditions: diminishes swelling, pain and redness associated with acute inflammation. - Allergic reactions: suppresses hypersensitivity responses and reduces edema. - Autoimmune disorders: moderates immune system activity to limit tissue damage. - Arthritis: alleviates joint inflammation and improves mobility.

Adverse reactions may vary with dose, duration and route of administration.

Common Side Effects: - Hyperglycemia: elevated blood sugar levels, especially in diabetic patients. - Insomnia: difficulty falling or staying asleep. - Increased appetite: may lead to weight gain. - Mood changes: irritability, euphoria or depression. - Gastro‑intestinal discomfort: nausea or abdominal pain.

Serious or Rare Side Effects: - Adrenal suppression: reduced endogenous cortisol production. - Severe infection: heightened risk of bacterial, viral or fungal infections. - Gastro‑intestinal bleeding or ulceration. - Anaphylactic reaction: sudden, severe allergic response. - Osteonecrosis: bone tissue death, particularly with prolonged use.

Careful assessment and monitoring are required before and during therapy. - Pregnancy: safety not established; use only if benefits outweigh risks. - Infection: avoid initiating therapy in active systemic infections. - Blood glucose: monitor diabetic patients closely for hyperglycemia. - Bone health: consider calcium and vitamin D supplementation during long‑term use. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Dexamethasone phosphate can alter the activity of several co‑administered drugs.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase steroid exposure. - Live vaccines: risk of attenuated infection due to immunosuppression. - Systemic antifungals (e.g., itraconazole): can potentiate glucocorticoid effects.

Moderate Interactions (Monitor Closely): - NSAIDs: increased risk of gastrointestinal ulceration. - Anticoagulants (e.g., warfarin): may enhance anticoagulant effect. - Diuretics: potential for hypokalemia. - Antidiabetic agents: may require dose adjustment for hyperglycemia.